Aarti Industries Limited announced its consolidated financial results for the first quarter ended June 30, 2026, reporting revenue from operations of Rs 2627 crore, a 41% year-on-year increase, and profit after tax of Rs 155 crore, a 260% year-on-year increase. The company’s Rs 700–800 crore capital expenditure program for fiscal year 2027 remains on track, and it achieved the EcoVadis Platinum Rating with a score of 87/100, placing Aarti Industries among the top 1% of companies globally for sustainability performance. The company expects volumes to recover in the second quarter following disruptions related to geopolitical tensions in West Asia.

Aavas Financiers Limited announced the allotment of 20,000 Senior, Secured, Rated, Listed, Transferable, Redeemable Non-Convertible Debentures with a face value of Rs 100,000 each, aggregating to Rs 200 crore, following a private placement. The Executive Committee of the Board of Directors approved the allotment on July 30, 2026, with 6,000 debentures allocated to anchor investors and 14,000 to non-anchor investors, receiving a total settlement amount of Rs 200.2240 crore, including Rs 22.40 crore as premium. The debentures, with a coupon rate of 7.80% per annum, will mature on July 30, 2029, and are proposed to be listed on the Wholesale Debt Market of the BSE Limited.

Acme Solar Holdings Limited reported total revenue of Rs 954 crore for the quarter ended June 30, 2026, a 63.3% increase year-on-year, alongside an Rs 831 crore EBITDA, up 56.5% year-on-year, and a profit after tax of Rs 235 crore, up 79.9% year-on-year. The company achieved a quarterly capacity utilization factor of 30.9%, commissioned approximately 2.3 GWh of battery energy storage systems (BESS), bringing the total commissioned BESS capacity to approximately 3.62 GWh, and signed power purchase agreements (PPAs) for 600 MW of firm and dispatchable renewable energy/hybrid projects with SECI, increasing the total UC PPA signed capacity to 3,880 MW.

Active Clothing Co Ltd, with Scrip Code 541144, stated that it did not raise funds through a public issue, right issue, preferential issue, or QIP during the quarter ended June 30, 2026, rendering the statement of derivation or variation under Regulation 32(1) of the SEBI (LODR) Regulations, 2015 not applicable.

ADF Foods Limited announced that its board of directors approved the incorporation of a wholly owned step-down subsidiary, AD F Foods Ireland Limited, in Ireland to support the company's growth plans in Europe. The subsidiary will be incorporated with a cash consideration of EUR 20,000 and will be a wholly owned step-down subsidiary of ADF Foods Limited via its wholly owned subsidiary, ADF Foods UK Limited.

AEGIS LOGISTICS LTD. will hold a board meeting on Thursday, August 06, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and the trading window for company directors and designated persons will remain closed until Saturday, August 08, 2026.

AEGIS VOPAK TERMINALS LIMITED will hold a board meeting on Wednesday, August 05, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and the trading window for company directors and designated persons will remain closed until the end of business hours on Friday, August 07, 2026.

Afcons Infrastructure Limited announced that its shareholders approved the re-appointment of Subramanian Krishnamurthy as Executive Chairman and Srinivasan Paramasivan as Managing Director at the company's 50th Annual General Meeting on July 30, 2026. Both appointments are for a further term of two years, commencing July 1, 2026, and ending June 30, 2028. Krishnamurthy has served as Executive Vice Chairman since 2018 and previously as Managing Director from 2002, while Paramasivan has been Managing Director since 2002 and brings over four decades of experience in banking, finance, and infrastructure.

Ajanta Pharma Limited has set Wednesday, August 5, 2026, as the record date to determine shareholders eligible for the first interim dividend, according to a filing with the BSE Limited and National Stock Exchange of India.

Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, announced a net profit after tax of Rs 1,601 million for the first quarter ended June 30, 2026, a 31.8% year-over-year increase, alongside revenue from operations of Rs 6,404 million, up 6.4% year-over-year, driven by a 26.5% year-over-year growth in its non-GPL business. The company reported earnings before interest, taxes, depreciation, and amortization of Rs 2,341 million, a 29.1% year-over-year increase, with margins at 36.6%, and held cash and cash equivalents of Rs 8,802 million as of June 30, 2026.